Skip to main content
LIVE CIN BRIEFING
Macro: Cautious · Global: Expanding · Opportunities: Selective · CMHI: 28.9
FINANCIALS

Company Financial Data

Revenue, EPS, total assets, cash, and debt from SEC filings across all tracked cannabis companies.

View Data ↓
SIGNALS
BULLISH

GTI Revenue Growth Accelerates to 12%

Strongest quarterly top-line growth among tracked MSOs

COMPANIES

Trulieve Achieves Free Cash Flow Positive

First sustained FCF quarter signals operational maturity

ANALYST

Margin Improvement Trend Across Top MSOs

Operating leverage emerging as revenue scales

BEARISH

Balance Sheet Leverage Remains Elevated

Average D/E ratio above 1.5x across tracked cannabis companies

Data loading…
Ticker Company Revenue Net Income EPS Total Assets Cash D/E Mkt Cap
Loading financials…
Complimentary Research
Would you like a company financial deep dive?

Request a complimentary, fully customized report covering revenue drivers, margin analysis, and balance sheet assessment — focused on the companies you care about.

Request Complimentary Report

Terminal Dashboards

Markets
Live prices & movers
88 equities · Real-time data
Charts
Technical analysis
Interactive price history
Financials
SEC filings data
Revenue · EPS · Balance sheets
Analyst
Consensus estimates
Price targets · Ratings
Deals
Capital activity
Financing · Insider transactions
Macro
Economic context
Yields · VIX · USD · Fed
Global
International markets
13 countries · World Bank data

Disclaimer: Cannabis Investor News is for informational purposes only—not investment advice. We are not registered with the SEC, FINRA, or any regulatory body. Data may be delayed or inaccurate. Cannabis securities carry significant risk; you could lose your entire investment. Always consult a licensed financial advisor and verify all information independently before making any investment decision.

Cannabis Company Financials — Revenue, Margins, and SEC Data

Access fundamental financial data for publicly traded cannabis companies including revenue, gross margin, EBITDA, net income, cash position, total debt, and key operating metrics. CIN aggregates financial data from SEC 10-K and 10-Q filings, Canadian SEDAR disclosures, and verified financial data providers to present a standardized view of cannabis company fundamentals.

The financials dashboard enables comparison across cannabis operators by displaying quarterly and annual financial metrics in a consistent format. Key metrics tracked include revenue growth rates, adjusted EBITDA margins, free cash flow generation, and balance sheet strength indicators. Cannabis company financials are complicated by varying accounting treatments across U.S. GAAP and IFRS reporting standards — CIN normalizes presentation to facilitate cross-border comparisons between U.S. MSOs and Canadian LPs. Cannabis industry financial analysis requires understanding sector-specific factors including Section 280E tax treatment (which prohibits standard business deductions for Schedule I substances), state-by-state regulatory costs, and the impact of wholesale price compression on operator margins. CIN's financial data contextualizes these cannabis-specific dynamics within each company's reported results.

Historical financial data spanning multiple quarters enables trend analysis of revenue growth trajectories, margin expansion or contraction, and progress toward sustainable profitability — a key milestone for cannabis sector institutional investment adoption.